Sign In
Buy PCRX
$22.25
-0.710 (-3.09%)
At Close: Jun 02, 2026
Stifel Nicolaus Sticks to Their Hold Rating for Amarin (AMRN)
02:58am, Tuesday, 31'st Mar 2020
In a report released yesterday, Derek Archila from Stifel Nicolaus maintained a Hold rating on Amarin (AMRN), with a price target of $8.00. The company's
RBC Capital Maintains a Buy Rating on Perrigo Company (PRGO)
02:33am, Monday, 30'th Mar 2020
In a report issued on March 27, Randall Stanicky from RBC Capital maintained a Buy rating on Perrigo Company (PRGO), with a price target of $58.00. The
RBC Capital Maintains a Buy Rating on Perrigo Company (PRGO)
02:32am, Monday, 30'th Mar 2020
In a report issued on March 27, Randall Stanicky from RBC Capital maintained a Buy rating on Perrigo Company (PRGO
Zacks Investment Research Downgrades Pacira Biosciences (NASDAQ:PCRX) to Hold
10:40am, Sunday, 29'th Mar 2020
Pacira Biosciences (NASDAQ:PCRX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Friday, Zacks.com reports. They presently h
Traders Buy High Volume of Pacira Biosciences Call Options (NASDAQ:PCRX)
05:46am, Saturday, 28'th Mar 2020
Pacira Biosciences Inc (NASDAQ:PCRX) was the recipient of some unusual options trading activity on Friday. Stock investors bought 4,061 call options on the stock. This is an increase of 1,931% compare
RBC Capital Sticks to Its Buy Rating for Mylan (MYL)
01:08pm, Friday, 27'th Mar 2020
In a report released today, Randall Stanicky from RBC Capital maintained a Buy rating on Mylan (MYL), with a price target of $26.00. The company's shares
RBC Capital Sticks to Its Buy Rating for Mylan (MYL)
01:08pm, Friday, 27'th Mar 2020
In a report released today, Randall Stanicky from RBC Capital maintained a Buy rating on Mylan (MYL – Research Report),
RBC Capital Maintains a Buy Rating on Pfizer (PFE)
01:08pm, Friday, 27'th Mar 2020
In a report released today, Randall Stanicky from RBC Capital maintained a Buy rating on Pfizer (PFE), with a price target of $44.00. The company's shares
RBC Capital Maintains a Buy Rating on Pfizer (PFE)
01:08pm, Friday, 27'th Mar 2020
In a report released today,
Randall Stanicky
from RBC Capital maintained a
Buy
rating on Pfizer (
PFE
–
Research Report
), with a price target of
$44.00
. The company’s shares closed last Monday a
Pacira Biosciences (NASDAQ:PCRX) Shares Up 4.2%
10:28am, Friday, 27'th Mar 2020
Pacira Biosciences Inc (NASDAQ:PCRX)’s share price traded up 4.2% during mid-day trading on Wednesday . The stock traded as high as $31.99 and last traded at $31.53, 20,670 shares were traded during
Pacira Biosciences Inc (NASDAQ:PCRX) Expected to Announce Quarterly Sales of $109.62 Million
06:38am, Friday, 27'th Mar 2020
Equities analysts predict that Pacira Biosciences Inc (NASDAQ:PCRX) will report sales of $109.62 million for the current quarter, Zacks Investment Research reports. Eight analysts have issued estimate
Piper Sandler Trims Pacira Biosciences (NASDAQ:PCRX) Target Price to
07:50am, Thursday, 26'th Mar 2020
Pacira Biosciences (NASDAQ:PCRX) had its price target decreased by Piper Sandler from to in a research note released on Monday morning, The Fly reports. Other analysts have also recently issued report
RBC Capital Sticks to Its Buy Rating for Osmotica Pharmaceuticals (OSMT)
02:49pm, Wednesday, 25'th Mar 2020
In a report released today, Randall Stanicky from RBC Capital reiterated a Buy rating on Osmotica Pharmaceuticals (OSMT), with a price target of $10.00.
RBC Capital Sticks to Its Buy Rating for Osmotica Pharmaceuticals (OSMT)
02:49pm, Wednesday, 25'th Mar 2020
In a report released today,
Randall Stanicky
from RBC Capital reiterated a
Buy
rating on Osmotica Pharmaceuticals (
OSMT
–
Research Report
), with a price target of
$10.00
. The company’s shares c
RBC Capital Keeps a Buy Rating on Agile Therapeutics (AGRX)
02:47pm, Wednesday, 25'th Mar 2020
In a report released today, Randall Stanicky from RBC Capital reiterated a Buy rating on Agile Therapeutics (AGRX), with a price target of $8.00. The
